CDC5L interference inhibited the CAM-DR in MM cells to alleviate the promotion effects of ANXA7 overexpression on CAM-DR to make MM cells become more susceptible to bortezomib. The gene discussed is ANXA7; the disease is Miyoshi myopathy.